Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Scottsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
This phase I/II trial tests the safety, side effects, best dose, and effectiveness of multi-epitope folate receptor alpha-loaded dendritic cell vaccine (FRalphaDC) with pembrolizumab in treating patients with ovarian, fallopian tube, or primary peritoneal cancer (collectively known as ovarian cancer) that that has come back (after a period of improvement) (recurrent). Ovarian cancer is the most lethal gynecologic malignancy in the United States. While the majority of patients achieve a remission
Sponsor: Mayo Clinic
Check if you qualify for this ovarian cancer clinical trial in Scottsdale, AZ
If you're searching for ovarian cancer treatment options in Scottsdale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.